BackAscendis Pharma A/S Overview

Ascendis Pharma A/S Selling, General & Admin

See how ASND's SG&A expenses trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$146.18M
44.67% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$498.50M
54.78% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Ascendis Pharma A/S (ASND) FAQ

Stockcircle tracks selling, general & admin for Ascendis Pharma A/S (ASND), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Ascendis Pharma A/S's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ASND overview so you can move from this figure to the surrounding analysis quickly.